Finance

Lists
Q1 2027 earnings • in 4 days
See details
NEOG:NASDAQ
Neogen Corp
$12.44
+1.67%
(+0.20) 1D
Oct 2, 11:49:01 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NEOG...
Open
$12.40
High
$12.50
Low
$12.19
Mkt. cap
2.71B
Avg. vol.
3.46M
Volume
633.19K
52-wk high
$14.18
52-wk low
$5.37
EPS
-$0.04
Beta
1.79
Shares outstanding
218.11M
No. of employees
3K
Open
$12.40
High
$12.50
Low
$12.19
Mkt. cap
2.71B
Avg. vol.
3.46M
Volume
633.19K
52-wk high
$14.18
52-wk low
$5.37
EPS
-$0.04
Beta
1.79
Shares outstanding
218.11M
No. of employees
3K
News stories
From web sources and news partners
Profile
Neogen Corporation is an international food safety company that provides test kits and relevant products to detect dangerous substances in food. The company was founded in 1982 and is based in Lansing, Michigan. The company serves a wide range of countries including Canada, United States, the United Kingdom, parts of Europe, Mexico and Brazil, India, and China, among others. The company operates a product line of over 100 drug detection test kits worldwide for the detection of about 300 abused and therapeutic drugs in animal treatment. In 2009, it became a vendor of the Chinese government and has been engaged in researching China-specific food safety and plant health issues. Wikipedia
About Neogen Corp
CEOJohn Adent
Employees2.64K
Founded1982
Headquarters-
SectorMedical device
Websiteneogen.com
Analyst ratings
Based on 3 analysts giving stock ratings to NEOG in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NEOG in the last 3 months.
Highest
Current $12.44
$14.00 (+12.49%)
Average
$14.00 (+12.49%)
Lowest
$14.00 (+12.49%)
Analyst
Recommendation
Action
Price target
Projected
Date
Subbu Nambi
Guggenheim
Buy
Maintained
$14.00
+12.5%
09/29/2026
Brandon Vazquez
William Blair
Hold
Maintained
-
-
09/28/2026
David Westenberg
Piper Sandler
Buy
Maintained
$14.00
+12.5%
09/15/2026
Next call in 4 days
Tue, Oct 6, 10:30 PM
Fiscal period
Q1 2027
EPS / Est. (USD)
- / $0.05
Revenue / Est. (USD)
- / 208.18M
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Aug 2025
Nov 2025
Feb 2026
May 2026
Revenue
209.19M
224.69M
211.20M
225.30M
Cost of goods sold
114.22M
118.01M
112.20M
117.50M
Cost of revenue
114.22M
118.01M
112.20M
117.50M
Research and development expenses
5.12M
4.56M
3.80M
4.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
105.94M
107.50M
98.50M
99.80M
Operating expense
111.06M
112.06M
102.30M
104.70M
Total operating expenses
225.28M
230.07M
214.50M
222.20M
Operating income
-16.09M
-5.38M
-3.30M
3.10M
Other non operating income
-1.10M
-477.00K
-3.10M
4.50M
EBT including unusual items
43.81M
-20.36M
-20.30M
-12.10M
EBT excluding unusual items
-32.58M
-20.36M
-20.30M
-12.10M
Income tax expense
7.47M
-4.44M
-3.30M
-800.00K
Effective tax rate
17.05%
21.80%
16.26%
6.61%
Other operating expenses
-
-
-
-
Net income
36.34M
-15.92M
-17.00M
-11.30M
Net profit margin
17.37%
-7.09%
-8.05%
-5.02%
Earnings per share
0.04
0.10
0.09
0.09
Interest and investment income
918.00K
592.00K
-
-
Interest expense
-16.44M
-14.85M
-13.90M
-13.90M
Net interest expenses
-15.52M
-14.26M
-13.90M
-13.90M
Depreciation and amortization charges
-
-
-
-
EBITDA
12.96M
23.55M
25.62M
32.50M
Gain or loss from assets sale
-75.69M
267.00K
224.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps